arrow
N

Nicolas Zhou

university of texas system
H指数:16
被引数:1,968

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant nivolumab and nivolumab plus ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159

新辅助纳武利尤单抗及纳武利尤单抗联合伊匹木单抗在可切除非小细胞肺癌中的应用:NEOSTAR和CA209-159研究的5年结果联合分析

2024-09-010
PRE
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations

胸膜间皮瘤对新辅助治疗的影像学反应应作为患者选择减瘤手术的指南

2023-08-110
OAAI
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

新辅助化疗联合nivolumab加或不加ipilimumab治疗可手术非小细胞肺癌: 2期平台NEOSTAR试验

2023-03-1694
OAAI
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy
2020-08-3025
OAAI